Pay in 4 interest-free payments of $5.89 Learn more
Ships within 48 hours · Estimated delivery Nov 7 - Nov 12
A simple once-daily tablet with no injections required
Adequate Sleep 7-8 hours of quality sleep per night
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist approved by the FDA for managing type 2 diabetes mellitus and chronic weight management
In 2024, there were 8.4 million prescriptions and $8.6 billion in spending on GLP-1s in Medicaid, and 21.8 million claims and $27.5 billion in gross spending (not excluding rebates) on GLP-1s in Medicare (Figure 1)
00:11:49 Vickie Danaher But theres no evidence that combos work better to improve weight loss or glycemic control, and it likely increases the risk of side effects, especially nausea, vomiting, and GI intolerance
The first oral semaglutide formulation approved specifically for obesity was cleared by the FDA in late 2025, expected to reach pharmacies in Q2 2026
US$ 28.53
US$ 29.72
US$ 23.06
US$ 21.51
US$ 26.58
